🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, pharmacokinetic and ph...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10-31
Trial ID
NCT04460105
Treatments Being Tested
The primary objective of this study is to evaluate the time to confirmed cl...
Status
Completed
Location
Pinnacle Research Group LLC
Start Date
2020-11-24
Trial ID
NCT04590586
The purpose of this study is to evaluate bioavailability of lanadelumab (SH...
Status
Completed
Location
Clinical Pharmacology of Miami, LLC
Start Date
2019-05-14
Trial ID
NCT03918239
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK), safety ...
Status
Completed
Location
WCCT Global, Inc.
Start Date
2018-01-15
Trial ID
NCT03401671
Treatments Being Tested
So far little is very few drugs have demonstrated positive results for trea...
Status
Completed
Location
Amsterdam UMC
Start Date
2020-10-30
Trial ID
NCT04422509
Treatments Being Tested
The purpose of this phase 3, open-label, multi-center study is to evaluate ...
Status
Completed
Location
Toyohashi Municipal Hospital
Start Date
2019-12-12
Trial ID
NCT04180163
Treatments Being Tested
The main aim of this study is to evaluate the safety of lanadelumab in Chin...
Status
Completed
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2022-06-22
Trial ID
NCT05460325
Treatments Being Tested
This study is an open-label, long term safety and efficacy study to evaluat...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2016-05-26
Trial ID
NCT02741596
The main aim of this study is to check if repeated subcutaneous (SC) inject...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2020-05-04
Trial ID
NCT04206605
Treatments Being Tested
use of lanadelumab in patients with acquired angioedema...
Status
Recruiting
Location
Bernstein Clinical Research Center, LLC
Start Date
2024-06-01
Trial ID
NCT06818474
Treatments Being Tested